• 
• http://www.nature.com/reviews/drugdisc
• Editor: Peter Kirkpatrick
• Volume 7: 12 issues per year
• ISSN: 1474-1776
• EISSN: 1474-1784
• Impact factor : 23.308*
• Impact ranking: 1/138 in Biotechnology & Applied Microbiology; 1/205 in Pharmacology & Pharmacy*
• Date Established: January 2002
• Published on behalf of:

No. 1 journal in Pharmacology & Pharmacy
No. 1 journal in Biotechnology & Applied Microbiology

Aims and Scope:

Nature Reviews Drug Discovery integrates academia and industry, providing broad, expert coverage of the drug discovery and development arena - from disease mechanisms, novel therapeutic approaches and chemistry to clinical trials and regulatory affairs. All reviews are carefully commissioned, written by leaders in the field and subject to rigorous peer-review so that readers receive independent, high-quality and authoritative articles in each issue. Reviews are complemented by news stories that investigate the key issues in drug discovery, timely summaries of significant published papers, market analysis, and updates on the latest advances in fast-moving areas such as new technologies, drug approvals and patent law.

Information is presented at several levels and can be tailored to your users' individual needs. Non-specialists will benefit from the glossary and highlighted references, and experts will appreciate the insight provided by top names in their field. Nature Reviews Drug Discovery is a major teaching and reference resource from NPG.

Readership:

People with an interest in the science and business of drug discovery and development, including: biologists, chemists, pharmacologists, toxicologists, informaticians, clinicians, regulatory affairs professionals and pharmaceutical analysts.

Organized into four sections, Nature Reviews Drug Discovery provides:

• News and analysis - news features that explore the science behind the top stories, expert analysis of key therapeutic markets, patent news and information on the latest drugs.
• Highlights - short updates on new papers, including details of new web resources in short 'WebWatch' articles.
• Reviews - commissioned from leaders in the field, Reviews vary in length, depending on the topic. All Reviews are supplemented with glossary explanations for non-specialist readers, as well as highlighted references that are accompanied by an explanation as to why these references are essential reading. Some content from each issue is made available online ahead of print publication by Advance Online Publication (AOP).
• Perspectives - there are several types of Perspectives articles covering broader issues:
  • Timeline - Historical foundations and influences, or possible future directions
  • Opinion - An opportunity to present particular views on a topic
  • Science and Society - The implications and applications of science in our society
  • Innovation - New technologies
  • Outlook - strategic and business issues

What makes Nature Reviews Drug Discovery stand apart from all other review journals?

• Outstanding Quality and Authority - the journal provides carefully commissioned articles, peer reviewed by acknowledged leaders in the field. This is reflected in its impact factor of 18.775*, making it the most highly cited monthly review journal in pharmacology and pharmacy.
• Unrivalled Breadth and Depth - ensuring full coverage of the drug discovery discipline, focusing each month on topics of significance to the field.
• Greater Accessibility - all articles published in Nature Reviews Drug Discovery are enhanced with additional background information which is ideal for non-specialists. Busy scientists will appreciate the 'At-a- glance' summaries, and experts will value the insight provided by top names in their field.
• Superb Teaching Resource - Nature Reviews Drug Discovery explores and explains the development of new ideas and scientific progress within the primary literature. Each article is extensively edited and crafted to provide a clear picture of the latest research for students, scientists and teachers alike. Exclusive features include full-color Powerpoint figures; slide shows; animation; highlighted references; further reading and glossaries.
• Enhanced User Functionality - Nature Reviews Drug Discovery's website has been recently redesigned to enhance navigation and retrieval of information.


"I've been ten years in the industry waiting for a journal like this!"
Kevin Pang, Vice President, Decision Resources Inc.

Online features and site license access:

• Online archive available back to January 2002.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
• Unique online functionality includes figures and tables that can be downloaded as PowerPoint slides, 'Author links', 'At glance summaries' and links to 'Glossaries'.
• Special web focus issues in 2006 have included a Focus on Antibactericals.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in BIOBASE, BIOSIS, CAS, CSA, CAB Abstracts, EMBASE, Scopus, Current Contents, Science Citation Index and Medline (PubMed).

*2007 Journal Citation Report (Thomson Reuters, 2008)